Current Value of Holding

$192 Thousand

Shares

21.4 Thousand

% of Portfolio

0.00%

Average Buy Price

$9.3

Avg closing price
Price range

4 Jefferies Group Theravance Biopharma Trades

Jefferies Group acquired 21.4 Thousand Theravance Biopharma shares worth $192 Thousand. That's 0.00% of their equity portfolio (1001st largest holding). The first Theravance Biopharma trade was made in Q2 2023. Since then Jefferies Group bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $199 Thousand, resulting in a loss of 3.4%.

Avg closing price
Price range
New holding (+21.4 Thousand shares) Q1 2025
Avg closing price $9.30
Price range $8.44 - $10.47
Sold -302 Thousand shares Q4 2023
Avg closing price $10.06
Price range $8.58 - $11.40
Increased shares by 0.7% (+2.13 Thousand shares) Q3 2023
Avg closing price $9.65
Price range $8.38 - $10.44
New holding (+300 Thousand shares) Q2 2023
Avg closing price $11.04
Price range $10.16 - $11.92

News about Theravance Biopharma Inc and Jefferies Group

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!